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6 This study evaluated the chronic effects of nitrate (NO3-) ingestion over three days, on  40 km 
7 TT performance in 11trained cyclists (VO2max: 60.8 ± 7.4 ml.kg-1.min-1; age: 36 ± 9 years; 
8 height: 1.80 ± 0.06 m; body mass: 87.2 ± 12.0 kg). Utilising a double blind randomised cross-
9 over design, participants completed three 40 km TT on a Velotron® ergometer following the 
10 ingestion of either a 140 ml of “BEET It sport®” NO3- shot containing 12.8 mmol or 800 mg of 
11 NO3-, a placebo drink or nothing (control). Performance, oxygen consumption (VO2), blood 
12 bicarbonate (HCO3-), pH and lactate (BLa) and ratings of perceived exertion (RPE) were 
13 measured every 10 km throughout the TT. The present findings show that NO3- ingestion had 
14 no effect on TT performance (NO3-: 4098.0 ± 209.8 vs. Placebo: 4161.9 ± 263.3 s, p = 0.296, 
15 ES = 0.11), or VO2 (p = 0.253, ES = 0.13). Similarly, blood lactate and RPE were also 
16 unaffected by the experimental conditions (p = 0.522, ES = 0.06; p = 0.085, ES = 0.30) 
17 respectively. Therefore, these results suggest that a high dose of NO3- over three days has 
18 limited efficacy as an ergogenic aid for 40 km TT cycling performance in trained cyclists. 
319 Introduction 
20 Intake of exogenous dietary nitrates (NO3-) through supplementation and whole foods are 
21 associated with beneficial cardiovascular health outcomes and are used as an ergogenic aid 
22 for athletic performance (Clements et al., 2014). Green leafy vegetables and root vegetables 
23 are examples of NO3- rich dietary sources, while commercially available beetroot supplements 
24 provide a highly concentrated and practical method to ingest NO3- prior to exercise. The 
25 underlying action of NO3- is derived from the enhanced bioavailability of nitric oxide (NO), 
26 which can be synthesised via continuous reactions in the L-arginine-NO pathway (Moncada 
27 and Higgs, 1993) or reduced from NO3- (Lundberg et al., 2004). The latter is prominent in 
28 deriving NO from dietary beetroot supplementation, with NO3- reduced to nitrite (NO2) in the 
29 oral cavity (Duncan et al., 1995). Thereafter it is reduced to NO during downstream reactions 
30 and absorbed into circulating plasma (Lundberg et al., 2004). Nitric oxide consequently 
31 diffuses into the vascular smooth muscle where it acts as a gaseous signalling molecule for 
32 numerous physiological processes. 
33
34 Nitric oxide is predominantly cited as a potent vasodilator (Kelm and Schrader, 1990); but is 
35 also central to the processes of muscle contraction (Reid, 2001), mitochondrial respiration 
36 (Brown, 1999) and immunoregulation (Bogdan, 2001). Indeed, the effect on these 
37 physiological systems has led to NO3- rich supplements demonstrating beneficial effects on 
38 the oxygen cost of moderate intensity exercise (Larsen et al., 2010) and gross efficiency 
39 (Larsen et al., 2007). Therefore, mediating an improvement in mitochondrial efficiency (Larsen 
40 et al., 2011) and reducing the ATP demand of muscular contractions during exercise (Bailey 
41 et al., 2010). Cermak et al. (2012a) found a significantly improved 10 km TT performance 
42 (after 60 min of submaximal exercise) and power output compared to the placebo condition.  
43 Given these promising physiological responses mediated by NO3-, the ergogenicity of 
44 concentrated beetroot supplementation is translated into improved time to exhaustion (TTE) 
45 and time trial (TT) performance by some authors (Lansley et al., 2011; Bailey et al., 2009; 
46 Larsen et al., 2010; Cermak et al., 2012a). This beneficial effect is most apparent during 
447 shorter duration performance bouts, where an intensity equivalent to the severe intensity 
48 domain is undertaken (Bailey et al., 2009; Kelly et al., 2014). Time trial events of short 
49 durations (4 - 16 km), that require a relatively high exercise intensity, have also reported an 
50 ergogenic benefit (Lansley et al., 2011 Cermak et al., 2012a); however, no studies have 
51 investigated the effects of this dietary supplement on 40 km TT performance.
52
53 Despite the positive outcomes, the overall meta-analytic effect of NO3- on TT performance is 
54 considered to be unclear (standardised mean difference ± confidence interval: -0.1 ± 0.06; 
55 McMahon et al., 2016). This differential effect could be attributed to the training status of 
56 participants and/or the intensity of the bout not eliciting a sufficient physiological demand 
57 (Jones, 2014). Indeed, no effects have been observed during prolonged (> 30 min) TT 
58 performance from beetroot juice supplementation within highly trained individuals with VO2max 
59 of >60 ml·kg-1·min-1 (Cermak et al., 2012b; Wilkerson et al., 2012; Lane et al., 2013). Wilkerson 
60 et al., (2012) administered 500 ml beetroot juice containing 6.2 mmol of NO3- prior to an 80 
61 km TT, however the participants exhibited only a small 25% increase in plasma NO2 compared 
62 to the 139% increases observed in earlier studies with a similar participant cohort with an 
63 identical dose (Lansley et al., 2011). Indeed, a strong negative correlation between plasma 
64 NO2 increase and TT performance improvement was reported (r = -0.85; p = 0.01); thus, 
65 highlighting the importance of a high bioavailable NO for performance improvements.  
66 However, two separate doses 12 hrs apart, increasing total NO3- ingestion to 17.4 mmol prior 
67 to exercise, also reported no ergogenic effects during a 43.8 km TT (Lane et al. 2013). These 
68 authors, however, utilised a superiorly trained participant cohort (VO2max: 71.6 ± 4.6), which 
69 may explain the lack of improvement. Therefore, on the basis of previous work, the aim of this 
70 study was to evaluate the chronic effects of nitrate (NO3-) ingestion over three days, on  40 km 
71 TT performance in trained cyclists.
72
73 Methods
574 Eleven trained cyclists (VO2max 60.8 ± 7.4 ml.kg-1.min-1; age: 36 ± 9 years; height: 1.80 ± 0.06 
75 m; body mass: 87.2 ± 12.0 kg) volunteered to participate in this study. The cyclists had a 
76 minimum of one year cycling experience and a minimum weekly training volume of (5 hr.wk-1; 
77 and >150 km.wk-1). The research was approved by the Departmental Ethics Committee and 
78 participants gave written informed consent prior to any data collection. The participants were 
79 categorised as trained competitive cyclists (De Pauw et al., 2013), who were fully familiar with 
80 similar cycling TT distances and laboratory testing procedures.
81
82 Participants were required to visit the laboratory to complete a preliminary VO2max test which 
83 used a ramp incremental exercise test on an electronically braked cycle ergometer (Lode 
84 Excalibur Sport, Groningen, Netherlands). Participants were required to cycle at an initial 
85 intensity of 75 W for 1 min, after which the intensity increased at a ramp rate of 30 W.min-1 
86 until volitional fatigue. Breath-by-breath pulmonary gas exchange data was collected 
87 continuously using a gas analysis system (K5, Cosmed, Italy) during the incremental test and 
88 subsequently analysed using 5 s averaging. The VO2max was calculated as the highest 15 s 
89 mean value attained before the participants’ volitional termination of the test. Following 
90 completion of this test participants were familiarised with the Velotron® (RacerMate Inc, 
91 Velotron, USA) in order to ensure that the specific frame geometry settings were recorded for 
92 use in all subsequent TT laboratory visits.
93
94 Participants were then required to attend the laboratory on a further three separate occasions 
95 at the same time of day. Prior to each of these subsequent visits, participants recorded dietary 
96 intake and physical activity, which was replicated for the 24 h preceding each visit. They were 
97 also instructed to attend euhydrated, having abstained from caffeine and food ingestion a 
98 minimum of 4 h prior to the start of exercise. Participants were also told to avoid the use of 
99 antibacterial mouthwash during the ingestion and testing periods. Using a randomised 
100 crossover design, the experimental conditions of nitrate, placebo and control were 
101 administered. This required participants to ingest either 140 ml of beetroot juice (BEET It sport 
6102 ® UK) containing 12.8 mmol of NO3- (Larsen et al., 2010) or 140 ml of blackcurrant (P) sugar 
103 free cordial (Shannon et al., 2016) once per day for three days. Experimental drinks were 
104 consumed 3 h prior to the intended exercise time. In the control condition, participants 
105 consumed no experimental supplement. A 48 h period between each ingestion strategy was 
106 imposed to ensure adequate washout of supplementary NO3- (Lansley et al., 2011).
107
108 The exercise trials required participants to perform a self-selected warm-up for 5 min, which 
109 was then replicated prior to all subsequent trials. Exercise performance was then assessed 
110 using a 40 km TT at each of final three laboratory visits to assess the effects of the 
111 experimental conditions. The TT’s were performed on an electronically braked cycle 
112 ergometer (Velotron, Racermate, Seattle, USA) which allowed participants to see an avatar 
113 representation of their performance via software (Velotron 3D, Racermate, Seattle, USA), 
114 which recorded time, distance, power, and speed. At 10 km intervals, measurements of heart 
115 rate (T31, Polar, Finland), ratings of perceived exertion (Borg 1982), felt arousal (Svebak and 
116 Murgatroyd, 1985), respiratory gases (VO2) (K5, Cosmed, Italy) and fingertip capillary blood 
117 samples were obtained. Blood samples were analysed to determine blood pH and bicarbonate 
118 ion (HCO3-) concentrations (ABL800 basic, Radiometer, Denmark) and blood lactate (Lactate 
119 Pro2 LT-1730, Arkray, Japan). During the TT all performance data were obscured from view 
120 apart from distance completed and remaining. Participants received no verbal or temporal 
121 feedback, or any encouragement during the TT. 
122
123 Statistical Analysis
124 Data were assessed for normality using standard graphical procedures. All respiratory and 
125 blood biochemical responses, RPE, felt arousal, heart rate and mean performance indicators 
126 (time, speed and power output) were analysed using repeated measures ANOVA. Post-hoc 
127 pairwise comparisons were made using a Bonferroni procedure. Effect sizes were calculated 
128 using partial eta squared (ƞp2), and were interpreted as: a small (< 0.01), medium (0.01 - 
7129 0.06) or a large (≥ 0.14) effect. Statistical significance was set at p < 0.05 and all procedures 
130 were conducted using SPSS for Windows (Version 22, IBM®, Chicago, USA). 
131
132 Results
133 Ingestion of the NO3- drink had no significant effect on overall TT performance time (figure 1 
134 a and 1b), mean power, or mean speed (f = 1.27, p = 0.296, ƞp2 = 0.11, f = 1.14, p = 0.339, 
135 ƞp2 = 0.10; and f = 1.15, p = 0.336, ƞp2 = 0.10) respectively. There was also no effect on 
136 either mean heart rate (f = 3.51, p = 0.054, ƞp2 = 0.31) or VO2 (f = 1.47, p = 0.253, ƞp2 = 
137 0.13), but there was a significant increase in VO2 (f = 25.68, p < 0.001, ƞp2 = 0.72) during TT 
138 performance in all conditions (figure 2). Similarly, lactate and RPE (Table 1) were unaffected 
139 by the experimental conditions (f = 0.67, p = 0.522, ƞp2 = 0.06; and f = 2.96, p = 0.085, ƞp2 = 
140 0.30) respectively, but increases in these variables (Table 1) were observed during the course 
141 of the TT’s (f = 41.98, p < 0.001, ƞp2 = 0.80; and f = 46.55, p < 0.001, ƞp2 = 0.87) for lactate 
142 and RPE respectively. In the case of lactate, concentrations at 40 km where elevated 
143 compared to all other distances (p < 0.001). Whereas RPE (Table 1) increased between 10-
144 20 km (p = 0.001), 20-40 km (p = 0.001), between 10-40 km (p < 0.001), and in the last 10 km 
145 of the TT (p = 0.014). Felt Arousal (Table 1) was unaffected by either the experimental 
146 condition (f = 1.85, p = 0.184, ƞp2 = 0.16) or during the TT (f = 1.66, p = 0.196, ƞp2 = 0.14).
147
148 [Insert Figure 1 Near Here]
149 [Insert Figure 2 Near Here]
150
151 The blood acid-base response variable of pH and HCO3 (Table 1) were also unaffected by the 
152 experimental conditions (f = 2.02, p = 0.158, ƞp2 = 0.17) and (f = 1.54, p = 0.239, ƞp2 = 0.13) 
153 respectively. There were however some perturbations in these variables during the course of 
154 the TT’s (f = 37.60, p < 0.001, ƞp2 = 0.79; f = 48.88, p < 0.001, ƞp2 = 0.83), for pH and HCO3 
155 respectively. The pH response was unchanged between 10 and 20 km (p = 0.060), but it was 
156 significantly elevated between 10-30 km (p = 0.006) and then decreased in the final 10 km (p 
8157 < 0.001). Between 10-30 km there was a significant increase in HCO3 (p = 0.017), but this 
158 then decreased rapidly in the final 10 km (p < 0.001).
159
160 [Insert Table 1 Near Here]
161
162 Discussion
163 The aim of this study was to investigate the effects of a 12.8 mmol·day-1 NO3- dose for three 
164 days prior the performance of a 40 km TT in trained cyclists. The principle performance 
165 findings suggest that NO3-, in the form of beetroot juice, elicited no significant improvements 
166 in time to completion or mean power output. These findings support previous research which 
167 have reported no change in performance in TT greater than 30 min in superiorly trained 
168 cohorts (Cermak et al., 2012b; Wilkerson et al., 2012; Lane et al., 2013). Nevertheless, this 
169 study is the first to utilise a chronic 3-day dosing strategy and therefore, suggesting that 
170 increasing the concentration of NO3- ingestion does not alter performance during a longer 
171 duration 40 km TT in trained cyclists. 
172
173 The 3-day supplementation protocol utilised in this study administered a total of 38.4 mmol of 
174 NO3- prior to exercise, which is substantially greater than the 6 to 17.4 mmol administered 
175 during previous investigations (Cermak et al., 2012b; Wilkerson et al., 2012; Lane et al., 2013). 
176 These studies reported a plasma NO2 increase by 25% (Wilkerson et al., 2012) and 96% 
177 (Cermak et al., 2012b) from baseline to pre-exercise. While we did not measure plasma NO2, 
178 Kelly et al., (2014) utilised a similar 3-day supplementation approach providing 25.2 mmol 
179 NO3- and reported a substantial 242% and 557% mean increase from baseline, in a similarly 
180 trained population (VO2max: 58.3 ± 6.3 ml·kg-1·min-1). Given a greater concentration of NO2 was 
181 supplemented in the current study it is fair to postulate a similar increase in plasma NO2, which 
182 is substantially larger then that previously reported during prolonged TT investigations 
183 (Cermak et al., 2012b; Wilkerson et al., 2012). Consequently, the lack of change in 
184 performance is unlikely to be caused by insufficient plasma NO2 bioavailability.
9185
186 A recent investigation by Shannon et al., (2017) highlighted the ergogenic effects of NO3- may 
187 be a manifestation of the exercise intensity and duration. Acute beetroot juice supplementation 
188 significantly improved 1500 m TT performance but not 10000 m TT performance in trained 
189 runners. The shorter distance requires a relatively higher intensity, thereby prompting an 
190 increase in pulmonary VO2 and HR demand, a greater perturbation to muscle metabolic milieu 
191 (e.g. Hydrogen ion and phosphate accumulation) and an increased recruitment of type 2 
192 muscle fibres. The underlying mechanism of NO3- ergoencity are vast, but include improved 
193 mitochondrial efficiency and reductions in muscle metabolic perturbations (Vanhatalo et al., 
194 2011), particularly within type 2 fibres where blood flow and O2 delivery appears to be 
195 enhanced (Ferguson et al., 2015). However, during the current investigation, the 40 km TT 
196 was performed at submaximal intensities and thus limiting type 2 fibre recruitment. The 
197 differentiation in fibre recruitment may therefore, explain the lack of improvement in the current 
198 study, in comparison to the ergogenic effects reported  in higher intensity 4 km and 16 km 
199 TT’s (Lansley et al., 2011). Interestingly, Wilkerson et al., (2012) observed a significant 
200 supplement effect during the final 16 km split of the 80.4 km TT, which was a higher intensity 
201 than preceding splits and is characterised by the common increase in power output commonly 
202 observed during the final part of TT performances (Jones et al., 2015). While this may suggest 
203 NO3- may be beneficial during stochastic activities and the final part of a TT, this effect was 
204 not observed in the current study; thereby questioning the application of NO3- in this context. 
205
206 In the present study there was no effect of NO3- on VO2, but in several studies reduced VO2 
207 has been reported (Bailey et al., 2012; Lansley et al., 2011). Typically, these studies have 
208 used shorter duration and therefore, higher intensity exercise protocols; however, Wilkerson 
209 et al., (2012) reported a significant increase in the power output: VO2 ratio, suggesting 
210 improved efficiency in well trained cyclist with VO2max values of 63 ± 8 ml.kg-1.min-1. This study 
211 also reported an increase in plasma NO3-, suggesting that the NO3- ingestion caused the 
212 established physiological adaptations of reduced ATP cost of muscle force production and 
10
213 increased mitochondrial functioning. Despite this, along with improvement in the final quintile 
214 of the TT, this was still not enough to elicit an overall improvement in TT performance following 
215 NO3- ingestion. The present respiratory response data showed no differences between 
216 conditions, which is in agreement with the work of Bourdillon et al., (2015) and Christensen et 
217 al., (2013) who also reported no change in VO2 and RER during 120 min submaximal cycling 
218 or in a subsequent 400 kcal TT in elite cyclists. Christensen et al., (2013), have suggested 
219 that training status, determined as a VO2max of 50 mL.kg-1.min-1 in this case, may limit the 
220 effectiveness of supplementation and therefore be a factor to explain the lack of difference 
221 found in the present study. 
222 Conclusion
223 The aim of this research was to investigate a high dose of NO3- supplementation over three 
224 days ingestion on trained cyclists performing a 40km TT performance. This represents a novel 
225 ingestion strategy in a highly ecologically valid TT distance. However, the ingestion of dietary 
226 NO3- had no significant effect on performance, failed to improve respiratory efficiency, lower 
227 blood acidity or affect psychological and physiological fatigue indicators. Therefore, the use of 
228 an ergogenic aid containing 12.8 mmol (800 mg) of NO3- each day for three days prior to a 40 
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342 Figure 1. Mean (± SD) overall 40 km performance time for each experimental condition (a) 
343 and individual performance responses (b).
344
345 Figure 2. Mean (± SD) VO2 responses during each experimental condition during the 40 km 
346 time trials. (*) Denotes a significant increase in VO2 from the other distances in all conditions 






352 Table 1. Mean (±SD) Blood metabolite and subjective rating scale responses to nitrate and 
353 placebo ingestion during 40 km cycle time trials. (*) Represents a significantly increase from 
354 all other distances (p < 0.001); (•) represents a significant change over the previous 30 km (p 
355 < 0.01); (∇) Denotes a significant decrease over the previous 10 km (p < 0.05); and (∆) 
356 represents a significant increase over the previous 10 km (p < 0.05).
357
Distance (km)
10 20 30 40
Lactate (mmol.l-1)
Control 5.15 ± 2.04 5.04 ± 2.47 6.56 ± 3.70 9.15 ± 3.47*•
Placebo 5.05 ± 2.14 4.95 ± 2.93 5.09 ± 3.03 8.75 ± 3.38*•
Nitrate 4.33 ± 2.05 3.97 ± 2.00 3.99 ± 2.06 7.79 ± 2.00*•
pH
Control 7.37 ± 0.05 7.39 ± 0.06 7.40 ± 0.05 7.34 ± 0.06∇
Placebo 7.40 ± 0.04 7.41 ± 0.05 7.42 ± 0.05 7.34 ± 0.06∇
Nitrate 7.39 ± 0.05 7.40 ± 0.06 7.41 ± 0.06 7.34 ± 0.07∇
HCO3- (mmol.l-1)
Control 20.81 ± 2.86 20.79 ± 3.13 21.20 ± 2.56 18.33 ± 2.43∇
Placebo 21.43 ± 2.17 21.88 ± 2.41 22.25 ± 2.52 18.58 ± 2.46∇
Nitrate 21.26 ± 2.37 21.43 ± 2.60 21.94 ± 2.91 17.79 ± 2.20∇
RPE
Control 14.0 ± 1.31 14.9 ± 2.0∆ 15.8 ± 2.6 19.4 ± 1.1•
Placebo 14.1 ± 1.7 15.3 ± 2.0∆ 16.0 ± 2.2 19.0 ± 1.2•
Nitrate 14.5 ± 2.3 15.8 ± 1.6∆ 16.5 ± 1.9 19.4 ± 1.2•
Felt Arousal
Control 4.18 ± 0.75 4.45 ± 1.04 4.64 ± 0.67 4.00 ± 0.77
Placebo 4.00 ± 0.77 4.00 ± 1.10 4.00 ± 1.34 4.18 ± 1.33
Nitrate 4.27 ± 1.01 4.45 ± 0.82 4.45 ± 0.69 4.64 ± 0.81
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